2022 Heart Failure Summit

Heart failure is a chronic progressive disease with over 6.5 million Americans affected, and researchers expect the number to increase to 8 million by the year 2030. Nearly all heart failure patients will have at least one hospitalization during their disease and one in four patients face readmission within 30 days of discharge.  In this complicated disease, there is nearly a 40% mortality rate within a year of their first hospitalization, taking a tremendous toll on the quality of life for patients, families, and caregivers.

Tune in on December 1st to hear from national thought leaders on heart failure prevention and management and to network with like-minded colleagues invested in improving outcomes for patients with a heart failure diagnosis. Earn 2.0 CE contact hours, including 0.75 pharmacology when you attend the event live or watch the recording afterwards.

Agenda

Thank you to our event sponsors for help making this event possible:

• Novartis Pharmaceuticals Corporation
• Merck Sharpe and Dohme Co
• Pfizer – Merck Alliance
• Abbott Laboratories.

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 03060